Resolution on allotment in directed share issue

UPPSALA, 17 March 2022.  As previously announced, the board of directors of Klaria Pharma Holding AB (“Klaria” or the “Company”) resolved on 11 March 2022, with support of the authorization from the annual general meeting held on 18 March 2021, to carry out a directed issue of new shares to approximately ten selected Swedish and international investors. All shares were subscribed for during the subscription period in accordance with the issue resolution, and the board of directors of Klaria has today resolved on allotment of in total 5,750,000 shares to the subscribers, in accordance with the board of director’s resolution on a directed share issue from 11 March 2022.